This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to the Alliance for Advancing Biomedical Research, a non-profit organization, to manage and operate the NCI's Federally Funded Research and Development Center (FFRDC) known as the Frederick National Laboratory for Cancer Research (FNLCR) located in Frederick, Maryland.
The contract has a ceiling value of $89,000,000,000 and a period of performance from January 17, 2025 through January 16, 2035. The original special notice solicitation announced NCI's intention to re-compete the FNLCR FFRDC contract, formerly known as the Operations and Technical Support contract. The FFRDC serves as a unique biomedical research facility that develops new technologies and translates basic science discoveries into novel agents for the prevention, diagnosis, and treatment of cancer, AIDS, and other diseases. The contract aims to attract high-quality personnel, maintain currency in fields of expertise, and provide rapid response capabilities to support the biomedical research community within NCI, NIH, and other federal agencies.
Generated 1/18/25, 9:05 AM